JIM - Clinical and Epidemiological Characteristics of 1,420 European Patients with mild‐to‐moderate Coronavirus Disease 2019

JIM - Clinical and Epidemiological Characteristics of 1,420 European Patients with mild‐to‐moderate Coronavirus Disease 2019

Journal of Internal Medicine

The clinical presentation of European patients with mild‐to‐moderate Covid‐19 infection is still unknown.

ncase - What Happens Next? COVID-19 Futures, Explained With Playable Simulations

ncase - What Happens Next? COVID-19 Futures, Explained With Playable Simulations

ncase"The only thing to fear is fear itself" was stupid advice.Sure, don't hoard toilet paper – but if policymakers fear fear itself, they'll downplay real dangers to avoid "mass panic". Fear's not the problem, it's how we channel our fear. Fear...
NEJM - Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19

NEJM - Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19

The New England Journal of MedicineThere is concern about the potential of an increased risk related to medications that act on the renin–angiotensin–aldosterone system in patients exposed to coronavirus disease 2019 (Covid-19), because the viral...
NEJM - Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19

NEJM - Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19

The New England Journal of MedicineCoronavirus disease 2019 (Covid-19) may disproportionately affect people with cardiovascular disease. Concern has been aroused regarding a potential harmful effect of angiotensin-converting–enzyme (ACE)...
THE LANCET - Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

THE LANCET - Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

No specific antiviral drug has been proven effective for treatment of patients with severe coronavirus disease 2019 (COVID-19). Remdesivir (GS-5734), a nucleoside analogue prodrug, has inhibitory effects on pathogenic animal and human...
NEJM - Children with Covid-19 in Pediatric Emergency Departments in Italy

NEJM - Children with Covid-19 in Pediatric Emergency Departments in Italy

The New England Journal of MedicineOn February 20, 2020, the incidence of Covid-19 began to rapidly escalate in Italy. By March 25, Italy had the second highest number of Covid-19 infections worldwide and the greatest number of deaths.
ECDC - Considerations for infection, prevention and control measures on public transport in the context of COVID-19

ECDC - Considerations for infection, prevention and control measures on public transport in the context of COVID-19

European Centre for Disease Prevention and Control

This document provides advice on personal protective measures on public transport (e.g. bus, metro, train, commuter boats).

NEJM - Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young

NEJM - Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young

The New England Journal of MedicineTo rapidly communicate information on the global clinical effort against Covid-19, the Journal has initiated a series of case reports that offer important teaching points or novel findings. 
NEJM - Covid-19 — A Reminder to Reason

NEJM - Covid-19 — A Reminder to Reason

The New England Journal of MedicineHow long will this pandemic last? When will we find a treatment or vaccine? Which drug should we give our patients? Will we run out of personal protective equipment (PPE)? When will everyone return to work? We...
THE LANCET - What policy makers need to know about COVID-19 protective immunity

THE LANCET - What policy makers need to know about COVID-19 protective immunity

About a third of the world is under lockdown as a public health measure to curb the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19).
NCBI - Neonatal Resuscitation Where the Mother Has a Suspected or Confirmed Novel Coronavirus (SARS-CoV-2) Infection: Suggestion for a Pragmatic Action Plan

NCBI - Neonatal Resuscitation Where the Mother Has a Suspected or Confirmed Novel Coronavirus (SARS-CoV-2) Infection: Suggestion for a Pragmatic Action Plan

National Center for Biotechnology InformationCoronavirus disease 2019 (COVID-19), caused by the novel SARS-CoV-2 virus, is rapidly spreading across the world. As the number of infections increases, those of infected pregnant women and children...
WHO - Strengthening Preparedness for COVID-19 in Cities and Urban Settings

WHO - Strengthening Preparedness for COVID-19 in Cities and Urban Settings

World Health OrganizationThis document is to support local authorities, leaders and policy-makers in cities and other urban settlements in identifying effective approaches and implementing recommended actions that enhance the prevention,...
JPIDS - Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2

JPIDS - Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2

Journal of the Pediatric Infectious Diseases SocietyAlthough Coronavirus Disease 2019 (COVID-19) is mild in nearly all children, a small proportion of pediatric patients develops severe or critical illness. Guidance is therefore needed regarding...
NIH - COVID-19 Treatment Guidelines

NIH - COVID-19 Treatment Guidelines

National Institutes of HeatlhThese Treatment Guidelines have been developed to inform clinicians how to care for patients with COVID-19. Because clinical information about the optimal management of COVID-19 is evolving quickly, these Guidelines...
Primeiro1718192022242526Último
Categorias

Categorias

Arquivo de Notícias

Arquivo